erlotinib, Tarceva (cont.)

Pharmacy Author:
Medical Editor:

PRESCRIBED FOR: Erlotinib is used for treatment of patients with metastatic or locally advanced non-small cell lung cancer (NSCLC) who have failed at least one previous round of chemotherapy. It also is used for maintenance of NSCLC that has not progressed after four cycles of platinum-based first line chemotherapy. Erlotinib is combined with gemcitabine to treat advanced unresectable metastatic prostate cancer and for pancreatic cancer.

SIDE EFFECTS: The most common side effects of erlotinib are:

Any of these can occur in about half of all patients who receive the medicine, but these effects are usually mild. There have been rare reports of serious lung disease, including deaths, in patients receiving erlotinib for treatment of NSCLC or other tumors.

Other important side effects include:

Medically Reviewed by a Doctor on 7/21/2015

Report Problems to the Food and Drug Administration

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.

Pill Finder Tool

Need help identifying pills and medications?
Use the pill identifier tool on RxList.

Back to Medications Index